Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK7791 + Phosphate Binders in Hemodialysis Patients with Hyperphosphatemia
NCT04766398Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in hyperphosphatemia, sponsored by Kyowa Kirin. Started Mar 2021; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT04766398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766398.